- Home
- PGY vs ETON Comparison
PGY vs ETON Comparison
Compare PGY & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PGY | ETON |
|---|---|---|
| Founded | 2016 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.3B |
| IPO Year | 2021 | 2018 |
Fundamental Metrics
Financial Performance| Metric | PGY | ETON |
|---|---|---|
| Price | $22.25 | $63.05 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 3 |
| Target Price | $34.50 | ★ $39.33 |
| AVG Volume (30 Days) | ★ 3.1M | 645.0K |
| Earning Date | 05-07-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 116.43 | N/A |
| EPS | ★ 0.77 | 0.41 |
| Revenue | ★ $1,301,360,000.00 | $79,950,000.00 |
| Revenue This Year | $14.27 | $40.90 |
| Revenue Next Year | $14.39 | $47.23 |
| P/E Ratio | ★ $28.34 | $157.15 |
| Revenue Growth | 26.07 | ★ 104.94 |
| 52 Week Low | $10.40 | $14.27 |
| 52 Week High | $44.99 | $66.37 |
Technical Indicators
Market Signals| Indicator | PGY | ETON |
|---|---|---|
| Relative Strength Index (RSI) | 59.81 | 74.94 |
| Support Level | $20.67 | $15.66 |
| Resistance Level | $23.22 | N/A |
| Average True Range (ATR) | 1.06 | 3.31 |
| MACD | -0.08 | 1.42 |
| Stochastic Oscillator | 64.85 | 94.72 |
Price Performance
Historical ComparisonAbout PGY Pagaya Technologies Ltd.
Pagaya Technologies Ltd is a product-focused technology company. It uses machine learning, a vast data network, and an AI-driven approach to offer comprehensive consumer credit and residential real estate products for its partners, their customers, and investors. Its suite of products includes Decline Monetization, Dual Look, First Look, Affiliate Optimizer Engine, Direct Marketing Engine, and FastPass, providing lenders with an AI-powered credit and acquisition ecosystem that helps them approve more borrowers, capture more demand, and grow without adding risk. Geographically, the company generates maximum revenue from its business in the United States.
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.